Phil Grayeski

Phil Grayeski is a highly experienced biotech venture capitalist and entrepreneur, currently serving as a Managing Partner at KdT Ventures. He has been instrumental in shaping KdT's investment strategy since Fund I, focusing on early-stage, science-driven companies across therapeutics, digital health, industrial biotechnology, and climate. His promotion to Managing Partner underscores his significant contributions and leadership within the firm. businesswire+2

With an impressive academic background including a PhD in Genetics from UNC Chapel Hill, an M.Phil. in Bioscience Enterprise from Cambridge, and a BS in Genetics and Chemistry from the University of Georgia, Phil is a physician-scientist who leverages his deep scientific expertise to identify and support transformative companies. His scientific acumen is a core asset in KdT's investment approach. marketscreener+2

Phil Grayeski has a strong entrepreneurial spirit, evidenced by his co-founding of Torque Bio and his involvement in spinning out other biotechnology companies from academia like StrideBio and Ribometrix. This hands-on experience as an early operator and founder gives him a unique perspective in his investment roles, enabling him to provide strategic insights to the startups he backs. marketscreener+1

Beyond his venture capital and entrepreneurial endeavors, Phil actively contributes to the biotechnology ecosystem through numerous board memberships. He serves as a board member for companies such as ZymoChem, Vecprobio (Cirsium Biosciences), Cyberdontics, and Andes, demonstrating his broad influence and commitment to advancing frontier science companies. marketscreener+1